Cerebroprotein Hydrolysate 90mg Tablets

Product Introduction

Cerebroprotein Hydrolysate 90mg Tablets are a peptide-based oral treatment used as an adjunct in selected neurological-care programmes. Evidence of clinical benefit is limited, and the tablets should not be assumed equivalent to injectable peptide preparations.

How to use

Take the prescribed oral tablet with or without food when the product permits. Track the functional goals selected by the neurologist; do not replace stroke prevention or rehabilitation with this treatment.

How it works

Peptide-related neurotrophic and neuroprotective actions have been proposed, but the mechanism and clinical benefit of the exact oral preparation are not firmly established.

Side effects

Headache, dizziness, nausea, agitation or allergic reactions may occur; the product's own adverse-effect information should guide follow-up.

Important information

Tell the treating team about seizures, severe kidney impairment or previous peptide-product reactions. New weakness on one side or speech difficulty requires emergency assessment.